Skip main navigation

You do not have any saved searches

  • Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes: Insights From a Cohort of 12 065 Patients With New-Onset Heart Failure

  • Hemodilution Is Common in Patients With Advanced Heart Failure

  • Anemia and Its Relationship to Clinical Outcome in Heart Failure

  • Prognostic Implication of Anemia on In-Hospital Outcomes After Percutaneous Coronary Intervention

  • Association of Hemoglobin Levels With Clinical Outcomes in Acute Coronary Syndromes

  • Effects of Reduced Hematocrit on Erythrocyte Velocity and Fluorescein Transit Time in the Cerebral Microcirculation of the Mouse

  • Intracerebral Hemorrhage in the Iron-Deficient Rat

  • Carotid Artery Thrombus Associated With Severe Iron-Deficiency Anemia and Thrombocytosis

  • Force Sensing by Piezo Channels in Cardiovascular Health and Disease

  • Abstract 10960: Red Cell Distribution Width and Mortality in Cardiorenal Anemia Syndrome

  • Comorbidity and Ventricular and Vascular Structure and Function in Heart Failure With Preserved Ejection Fraction: A Community-Based Study

  • Treating Anemia in Older Adults With Heart Failure With a Preserved Ejection Fraction With Epoetin Alfa: Single-blind Randomized Clinical Trial of Safety and Efficacy

  • Clinical Profile and Prognostic Value of Anemia at the Time of Admission and Discharge Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction: Findings From the EVEREST Trial

  • Heart Failure With Anemia: Novel Findings on the Roles of Renal Disease, Interleukins, and Specific Left Ventricular Remodeling Processes

    and for the ANCHOR Investigators
  • True Anemia―Red Blood Cell Volume Deficit―in Heart Failure: A Systematic Review

  • Accelerometer-Measured Daily Activity in Heart Failure With Preserved Ejection Fraction: Clinical Correlates and Association With Standard Heart Failure Severity Indices

  • Hyporesponsiveness to Darbepoetin Alfa in Patients With Heart Failure and Anemia in the RED-HF Study (Reduction of Events by Darbepoetin Alfa in Heart Failure): Clinical and Prognostic Associations